Morbidity and mortality after stroke--eposartan compared with nitrendipine for secondary prevention: principal results of a prospective randomized controlled study (MOSES).

Source:http://linkedlifedata.com/resource/pubmed/id/17362677

Download in:

View as

General Info

PMID
17362677